Table of Contents
Journal of Vaccines
Volume 2013, Article ID 618324, 8 pages
http://dx.doi.org/10.1155/2013/618324
Research Article

Immunogenicity and Protective Efficacy of a Polyvalent DNA Vaccine against Human Orthopoxvirus Infections Based on Smallpox Virus Genes

State Research Center of Virology and Biotechnology VECTOR, Koltsovo, Novosibirsk 630559, Russia

Received 26 May 2012; Accepted 11 July 2012

Academic Editor: Barbara Schnierle

Copyright © 2013 Rinat A. Maksyutov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Fenner, D. A. Henderson, I. Arita, Z. Jezek, and I. D. Ladnyi, Smallpox and Its Eradication, World Health Organization, Geneva, Switzerland, 1988.
  2. F. Fenner, “Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign,” Research in Virology, vol. 140, pp. 465–466, 1989. View at Google Scholar · View at Scopus
  3. S. N. Shchelkunov, S. S. Marennikova, and R. W. Moyer, Orthopoxviruses Pathogenic for Humans, Springer, New York, NY, USA, 2005.
  4. S. N. Shchelkunov, “How long ago did smallpox virus emerge?” Archives of Virology, vol. 154, no. 12, pp. 1865–1871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. N. Shchelkunov, “Emergence and reemergence of smallpox: the need in development of a new generation smallpox vaccine,” Vaccine, vol. 29, supplement 4, pp. D49–D53, 2011. View at Publisher · View at Google Scholar
  6. J. Stephenson, “Monkeypox outbreak a reminder of emerging infections vulnerabilities,” Journal of the American Medical Association, vol. 290, no. 1, pp. 23–24, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Lewis-Jones, “Zoonotic poxvirus infections in humans,” Current Opinion in Infectious Diseases, vol. 17, no. 2, pp. 81–89, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Campe, P. Zimmermann, K. Glos et al., “Cowpox virus transmission from pet rats to humans, Germany,” Emerging Infectious Diseases, vol. 15, no. 5, pp. 777–780, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Ninove, Y. Domart, C. Vervel et al., “Cowpox virus transmission from pet rats to humans, France,” Emerging Infectious Diseases, vol. 15, no. 5, pp. 781–784, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. W. Rimoin, P. M. Mulembakani, S. C. Johnston et al., “Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 37, pp. 16262–16267, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. G. Webster, E. F. Fynan, J. C. Santoro, and H. Robinson, “Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin,” Vaccine, vol. 12, no. 16, pp. 1495–1498, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. J. W. Hooper, K. I. Kamrud, F. Elgh, D. Custer, and C. S. Schmaljohn, “DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection,” Virology, vol. 255, no. 2, pp. 269–278, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Riemenschneider, A. Garrison, J. Geisbert et al., “Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus,” Vaccine, vol. 21, no. 25-26, pp. 4071–4080, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. S. N. Shchelkunov, “Functional organization of variola major and vaccinia virus genomes,” Virus Genes, vol. 10, no. 1, pp. 53–71, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. J. W. Hooper, D. M. Custer, C. S. Schmaljohn, and A. L. Schmaljohn, “DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge,” Virology, vol. 266, no. 2, pp. 329–339, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. J. W. Hooper, D. M. Custer, and E. Thompson, “Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates,” Virology, vol. 306, no. 1, pp. 181–195, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Sakhatskyy, S. Wang, T. H. W. Chou, and S. Lu, “Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen,” Virology, vol. 355, no. 2, pp. 164–174, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. W. Hooper, E. Thompson, C. Wilhelmsen et al., “Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox,” Journal of Virology, vol. 78, no. 9, pp. 4433–4443, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Heraud, Y. Edghill-Smith, V. Ayala et al., “Subunit recombinant vaccine protects against monkeypox,” Journal of Immunology, vol. 177, no. 4, pp. 2552–2564, 2006. View at Google Scholar · View at Scopus
  20. P. Sakhatskyy, S. Wang, C. Zhang, T. H. Chou, M. Kishko, and S. Lu, “Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens,” Virology, vol. 371, no. 1, pp. 98–107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. N. Shchelkunov, S. S. Marennikova, A. V. Totmenin et al., “Creation of a clone library of fragments from the natural variola virus and study of the structural and functional organization of viral genes from a circle of hosts,” Doklady Akademii Nauk SSSR, vol. 321, no. 2, pp. 402–406, 1991. View at Google Scholar · View at Scopus
  22. S. N. Shchelkunov, S. M. Resenchuk, A. V. Totmenin, V. M. Blinov, S. S. Marennikova, and L. S. Sandakhchiev, “Comparison of the genetic maps of variola and vaccinia viruses,” The FEBS Letters, vol. 327, no. 3, pp. 321–324, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. R. F. Massung, L. I. Liu, J. Qi et al., “Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975,” Virology, vol. 201, no. 2, pp. 215–240, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. S. N. Shchelkunov, A. V. Totmenin, V. N. Loparev et al., “Alastrim smallpox variola minor virus genome DNA sequences,” Virology, vol. 266, no. 2, pp. 361–386, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. S. N. Shchelkunov, A. V. Totmenin, I. V. Babkin et al., “Human monkeypox and smallpox viruses: genomic comparison,” The FEBS Letters, vol. 509, no. 1, pp. 66–70, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. Likos, S. A. Sammons, V. A. Olson et al., “A tale of two clades: monkeypox viruses,” Journal of General Virology, vol. 86, no. 10, pp. 2661–2672, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. S. N. Shchelkunov, P. F. Safronov, A. V. Totmenin et al., “The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins,” Virology, vol. 243, no. 2, pp. 432–460, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Q. Hu, C. A. Smith, and D. J. Pickup, “Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor,” Virology, vol. 204, no. 1, pp. 343–356, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. S. J. Goebel, G. P. Johnson, M. E. Perkus, S. W. Davis, J. P. Winslow, and E. Paoletti, “The complete DNA sequence of vaccinia virus,” Virology, vol. 179, no. 1, pp. 247–566, 1990. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Antoine, F. Scheiflinger, F. Dorner, and F. G. Falkner, “The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses,” Virology, vol. 244, no. 2, pp. 365–396, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. B. M. Baroudy and B. Moss, “Sequence homologies of diverse length tandem repetitions near ends of vaccinia virus genome suggest unequal crossing over,” Nucleic Acids Research, vol. 10, no. 18, pp. 5673–5679, 1982. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Mossman, C. Upton, R. M. L. Buller, and G. McFadden, “Species specificity of ectromelia virus and vaccinia virus interferon-γ binding proteins,” Virology, vol. 208, no. 2, pp. 762–769, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. E. J. Dick Jr., C. L. Kittell, H. Meyer et al., “Mousepox outbreak in a laboratory mouse colony,” Laboratory Animal Science, vol. 46, no. 6, pp. 602–611, 1996. View at Google Scholar
  34. A. Z. Maksyutov and E. S. Zagrebelnaya, “ADEPT: a computer program for prediction of protein antigenic determinants,” Computer Applications in the Biosciences, vol. 9, no. 3, pp. 291–297, 1993. View at Google Scholar · View at Scopus
  35. R. A. Maksyutov, I. N. Babkina, A. E. Nesterov, and S. N. Shchelkunov, “Creation of a candidate DNA vaccine against human orthopoxvirus infections,” Biotekhnologiya, vol. 4, pp. 23–30, 2006. View at Google Scholar
  36. N. A. Doria-Rose and N. L. Haigwood, “DNA vaccine strategies: candidates for immune modulation and immunization regimens,” Methods, vol. 31, no. 3, pp. 207–216, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. D. J. Pulford, A. Gates, S. H. Bridge, J. H. Robinson, and D. Ulaeto, “Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge,” Vaccine, vol. 22, no. 25-26, pp. 3358–3366, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Raz, D. A. Carson, S. E. Parker et al., “Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 20, pp. 9519–9523, 1994. View at Publisher · View at Google Scholar